ISO/IEC 42001 for AI Startups Selling to Healthcare, Banks and Insurers

What ISO/IEC 42001 is, and what it is not

ISO describes ISO/IEC 42001 as the first global standard that defines how to establish, implement, maintain and continually improve an AI management system. It applies to organizations of all sizes and sectors that develop, provide or use AI systems, which includes early-stage vendors.

Two limits matter for how you present it to buyers. First, certification is voluntary. An organization may choose it when it wants independent confirmation that its AI management system meets ISO/IEC 42001:2023, but it can implement the management system without certifying. Second, ISO states that the standard does not itself guarantee compliance. It is a management framework that helps an organization meet its compliance obligations more effectively. It does not replace HIPAA, state law or contract terms.

Official implementation guidance is also still pending. ISO/IEC AWI 42003, guidance on implementing ISO/IEC 42001, is listed as under development as of November 2026. Implementation planning therefore rests on the text of the standard itself and on your own judgment about how it applies to your product.

Scoping an implementation

Scope is the first decision and the one buyers examine most directly, because it determines what your statement of alignment or certification actually covers. A management system that covers the company in general but not the product a health system is buying will not answer the review.

Work through the scope in a fixed order, and record each decision so it can be shown to a reviewer.

• List the AI systems: Include every model, agent and AI feature that touches customer data or customer workflows, not only the flagship product.
• State your role per system: For each system, record whether you develop it, provide it or use a third-party component. The role changes which obligations you carry.
• Define boundaries: Name the environments, teams, hosting arrangements and subprocessors inside the management system, and those outside it.
• Decide certify or align: Choose whether to pursue independent certification or to operate an aligned management system. Describe the choice accurately in questionnaires.
• Assign owners: Name accountable roles for AI risk, data handling and approval of changes. Small teams can combine roles, but the assignments should be explicit.
• Relate existing attestations: Document how current security and privacy programs support the AI management system and what they do not cover.

Documentation versus controls that operate at runtime

A useful working distinction, though not language taken from the standard, is between artifacts that describe how you manage AI and controls that act on AI behavior while it runs. Management-system artifacts include the AI policy, role assignments, risk assessments, impact assessments and review records. They show intent, ownership and a cycle of improvement. A reviewer can read them, but they cannot show what a production system did to a specific record at a specific time.

Runtime controls are different. They constrain or record behavior as interactions and tool calls occur. When a buyer asks how PHI is handled by your AI features, a policy stating that PHI must be minimized is an artifact. A record showing that a given prompt contained PHI, that the PHI was redacted before reaching the model, and that a tool call was blocked or escalated for human approval is runtime evidence.

Buyers reviewing an AI vendor are likely to want both, and the second kind is where startups most often have gaps. The table below shows the pairing for common control areas.

Artifact and runtime evidence by control area

Each area needs a document that defines the expectation and, where behavior is involved, a record that shows the expectation was met in production.

• Policy and roles: Artifact: approved AI policy, named owners. Runtime evidence: policy rules that are actually enforced, with version history.
• Risk and impact assessment: Artifact: assessment per AI system and use case. Runtime evidence: records showing identified risks are constrained by active controls.
• PHI handling: Artifact: data handling procedure. Runtime evidence: per-interaction records of detection, redaction or blocking of PHI.
• Tool and system access: Artifact: access and permission standard. Runtime evidence: records of tool calls allowed, blocked or rate limited.
• Human oversight: Artifact: escalation procedure and approver roles. Runtime evidence: records of actions held for approval and the decision taken.
• Monitoring and improvement: Artifact: review schedule and corrective action records. Runtime evidence: continuous evidence that feeds those reviews.

What healthcare reviews probe, and how banks and insurers compare

Healthcare security reviews start from HIPAA. The Security Rule's technical safeguards sit in 45 CFR 164.312, and 164.312(b) addresses audit controls. For an AI vendor, the practical question is whether you can show, from records your system produces, how AI interactions and tool calls handled electronic PHI. Check the current regulatory text directly when you write control descriptions, and keep the descriptions aligned to it as of November 2026.

Expect review questions along these lines: which AI systems and roles are in scope of the management system, whether you are certified or only aligned, what operational evidence shows PHI handling in production beyond written policy, how your records support HIPAA technical safeguards, and how the AI management system relates to your existing security attestations and what gaps remain. These are the questions to prepare answers and exhibits for before a review begins.

Banks and insurers apply similar scrutiny to AI vendors, with the emphasis moving from PHI to customer financial and policyholder data and to the regulatory frameworks that govern those sectors. The same split applies: a documented management system, plus records showing how AI behavior was controlled. Building evidence once, at the interaction level, lets you answer all three buyer types without rebuilding exhibits for each.

Where runtime policy enforcement produces evidence

Enforcement in the execution path generates evidence as a by-product of controlling behavior. Trussed enforces policy on individual interactions and tool calls, with actions that include allow, redact, block, rate limit and escalate for human approval. Because the policy is enforced at runtime, not reviewed after the fact, each decision leaves a durable record of what the AI was allowed to do and what it did. That evidence is mapped to HIPAA, NIST and the EU AI Act, among other regimes, which gives a startup a consistent set of exhibits for buyer reviews.

The scope is deliberate and narrow. Enforcement operates at the level of single interactions and tool calls. It does not by itself provide model or dataset provenance, end-to-end tracing of agentic workflows, or certification. Those remain separate parts of your management system and need their own artifacts. Trussed runs in production with healthcare and pharma organizations, and it can be self-managed in the customer cloud, with configurable retention and data residency. That matters where a health system wants evidence to stay within its own environment.

Whether or not you use any particular product, the design principle holds. Decide which controls must act at runtime, make sure each one produces a record, and set retention so the records are available when a buyer or auditor asks for them.